Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
RemeGen Co. Ltd. Class H ( (HK:9995) ) has provided an announcement.
RemeGen Co., Ltd. announced the composition of its board of directors and their roles within various board committees. This announcement highlights the company’s commitment to maintaining a structured governance framework, which can positively impact its strategic decision-making and operational oversight.
More about RemeGen Co. Ltd. Class H
RemeGen Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating within the biotechnology and pharmaceutical industry. The company focuses on the development and commercialization of innovative medicines and therapies.
YTD Price Performance: -13.19%
Average Trading Volume: 2,516,602
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$12.06B
For detailed information about 9995 stock, go to TipRanks’ Stock Analysis page.
